Display options
Cite
Jamali R, Hatami N, Kosari F. The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease. Hepat Mon. 2016;16(5):e37412doi: 10.5812/hepatmon.37412.
Jamali, R., Hatami, N., & Kosari, F. (2016). The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease. Hepatitis monthly, 16(5), e37412. https://doi.org/10.5812/hepatmon.37412
Jamali, Raika, et al. "The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease." Hepatitis monthly vol. 16,5 (2016): e37412. doi: https://doi.org/10.5812/hepatmon.37412
Jamali R, Hatami N, Kosari F. The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease. Hepat Mon. 2016 Apr 20;16(5):e37412. doi: 10.5812/hepatmon.37412. eCollection 2016 May. PMID: 27313636; PMCID: PMC4906707.
Copy Download .nbib Format: NLM
Share it on

Hepat Mon. 2016 Apr 20;16(5):e37412. doi: 10.5812/hepatmon.37412. eCollection 2016 May.

The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease.

Hepatitis monthly

Raika Jamali, Neda Hatami, Farid Kosari

Affiliations

  1. Research Development Center, Digestive Disease Research Institute, Sina Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.
  2. Sina Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.
  3. Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, IR Iran.

PMID: 27313636 PMCID: PMC4906707 DOI: 10.5812/hepatmon.37412

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic hepatitis, which can lead to cirrhosis and hepatocellular carcinoma.

OBJECTIVES: The aim of the study was to evaluate the correlation between serum adipocytokines and the histologic findings of the liver in patients with non-alcoholic fatty liver disease (NAFLD).

PATIENTS AND METHODS: This case-control study was performed on those with persistent elevated liver enzymes and with evidence of fatty liver in ultrasonography. After exclusion of patients with other etiologies causing abnormal liver function tests, the resulting patients underwent liver biopsies. NAFLD was diagnosed based on liver histology according to the Brunt scoring system.

RESULTS: Waist circumferences and levels of blood glucose (after fasting), insulin, triglycerides, alanine aminotransferases (ALT), and aspartate aminotransferases (AST) were higher in patients with NAFLD than in those in the control group. ALT, AST, and gamma glutamine transferase (GGT) levels were lower in patients with liver steatosis of a grade of less than 33% than those with higher degrees of steatosis. Serum low-density lipoprotein (LDL), cholesterol, and hepcidin levels were significantly higher in those with lobular inflammation of grade 0 - 1 than in those with inflammation of grade 2 - 3 (Brunt score). Meanwhile, AST was significantly lower in those with lobular inflammation of grade 1 than in those with grade 2-3. Hepcidin and resistin levels were significantly higher in patients with moderate to severe fibrosis than in those with mild fibrosis.

CONCLUSIONS: It seems that surrogate liver function tests and adipocytokine levels were correlated with the histologic findings of the liver.

Keywords: Hepcidin; Liver Biopsy; Non-Alcoholic Fatty Liver Disease; Resistin; Visfatin

References

  1. Nat Clin Pract Gastroenterol Hepatol. 2005 Jun;2(6):273-80 - PubMed
  2. Am J Gastroenterol. 1999 Sep;94(9):2467-74 - PubMed
  3. Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):18-27 - PubMed
  4. Dig Dis Sci. 2009 Aug;54(8):1772-7 - PubMed
  5. Clin Exp Med. 2014 May;14(2):121-31 - PubMed
  6. Obes Surg. 2006 Sep;16(9):1118-25 - PubMed
  7. Hepat Mon. 2012 Oct;12(10 HCC):e6023 - PubMed
  8. Pol J Pathol. 2010;61(3):147-53 - PubMed
  9. Aliment Pharmacol Ther. 2008 Mar 1;27(5):412-21 - PubMed
  10. Ann Hepatol. 2010 Jul-Sep;9(3):266-70 - PubMed
  11. J Hepatol. 2011 Oct;55(4):920-32 - PubMed
  12. Metab Syndr Relat Disord. 2011 Aug;9(4):287-90 - PubMed
  13. Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G196-201 - PubMed
  14. Metabolism. 2011 Mar;60(3):313-26 - PubMed
  15. BMC Gastroenterol. 2014 Feb 23;14:39 - PubMed
  16. Ann Hepatol. 2013 Jul-Aug;12(4):548-55 - PubMed
  17. J Clin Endocrinol Metab. 2006 Mar;91(3):1081-6 - PubMed

Publication Types